Neurocrine Biosciences, Inc. (NBIX) — Fair Value Analysis
Base-case fair value (P50): $176.08 · Current price: $158.29 · Verdict: Fairly Valued
The Verdict on NBIX
Our Monte Carlo simulations indicate that NEUROCRINE BIOSCIENCES INC (NBIX) is Fairly Valued at its current market price of $158.29. The analysis, which models thousands of forward scenarios, pegs the median fair value (P50) for NBIX at $176.08. This valuation suggests an +11.2% potential upside from its current trading level. While offering a clear directional opportunity, this percentage gap falls within the range we define for a Fairly Valued equity, confirming that NBIX is not currently overvalued based on our robust modeling.
How NBIX stacks up against peers
NBIX demonstrates a strong quality tier, reflecting robust operational and financial health compared to its sector peers. This intrinsic strength is a critical factor influencing our Monte Carlo simulations, contributing to the stability and reliability of the $176.08 median fair value. A strong quality tier can help mitigate downside risks and provides a solid foundation for the company's long-term prospects, even within a competitive and dynamic market environment. The consistent performance supporting this tier underpins the rationale behind NBIX's Fairly Valued assessment relative to its $158.29.
What this means for investors
For investors, NBIX's current price of $158.29 aligning closely with our Fairly Valued verdict, and a P50 target of $176.08 representing +11.2% potential, suggests a balanced risk-reward profile. The company's strong quality tier provides a fundamental anchor, indicating resilience. While our simulations reveal potential for upside, investors should also consider the broader distribution of outcomes, including various bull and bear case scenarios that can differ significantly from the median. Through our FairCurve methodology, we provide these comprehensive insights. To understand the full distribution, including detailed bear and bull case targets and probability of upside, sign up for FairCurve to track NBIX's fair value as new fundamentals are released.
Frequently Asked Questions
Is NBIX overvalued or undervalued right now?
NBIX is currently trading at $158.29, which is below our Monte Carlo median fair value of $176.08. Based on this, NBIX is not considered overvalued but rather Fairly Valued.
What is the bear case and bull case for NBIX?
The full Monte Carlo distribution, including detailed bear case (P10) and bull case (P90) targets, plus the probability of upside, is available with a free FairCurve account. We do not disclose specific dollar values here.
How does FairCurve calculate NBIX's fair value?
FairCurve calculates NBIX's fair value by running Monte Carlo simulations over thousands of forward-looking scenarios to determine a probability distribution of potential future values, arriving at a median (P50) fair value.
How can I track NBIX's fair value as it changes?
You can add NBIX to a free FairCurve watchlist to receive daily fair-value updates. Your watchlist will also trigger instant re-valuation when new earnings or significant fundamental data are released.